Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/21709143/ below:

Organized colorectal cancer screening in integrated health care systems

Review

Affiliations

• ¹ Theodore.Levin@kp.org

• PMID: 21709143
• DOI: 10.1093/epirev/mxr007

Item in Clipboard

Review

Theodore R Levin et al. Epidemiol Rev. 2011.

• ¹ Theodore.Levin@kp.org

• PMID: 21709143
• DOI: 10.1093/epirev/mxr007

Item in Clipboard

Colorectal cancer (CRC) is an ideal target for early detection and prevention through screening. Noninvasive screening options are the guaiac fecal occult blood test and the fecal immunochemical test. Organized screening offers the promise of uniformly delivering screening to all members of a population who are eligible and due. Organized screening is defined as an explicit policy with defined age categories, method, and interval for screening in a defined target population with a defined implementation and quality assurance structure, and tracking of cancer in the population. The UK National Health Service; the Ontario, Canada Ministry of Health and Long-Term Care; and the US Veteran's Health Administration have used varied organized approaches to deliver guaiac fecal occult blood test screening to their populations. Kaiser Permanente Northern California began CRC screening in the 1960s, initially using flexible sigmoidoscopy. Implementation of organized fecal immunochemical test outreach was associated with improved Healthcare Effectiveness Data and Information Set CRC screening rates between 2005 and 2010 from 37% to 69% and from 41% to 78% in the commercial and Medicare populations, respectively. Organized fecal immunochemical test screening has been associated with an increase in annually detected CRCs, almost entirely because of increased detection of localized-stage cancers.

PubMed Disclaimer

• Screening for colon cancer: A test for occult blood.

  Khakimov N, Khasanova G, Ershova K, Gibadullina L, Vetkina T, Lobisheva G, Chumakova A. Khakimov N, et al. Int J Risk Saf Med. 2015;27 Suppl 1:S110-1. doi: 10.3233/JRS-150712. Int J Risk Saf Med. 2015. PMID: 26639687

• What Is Organized Screening and What Is Its Value?

  Dominitz JA, Levin TR. Dominitz JA, et al. Gastrointest Endosc Clin N Am. 2020 Jul;30(3):393-411. doi: 10.1016/j.giec.2020.02.002. Epub 2020 Apr 16. Gastrointest Endosc Clin N Am. 2020. PMID: 32439078 Review.

• Development of a Group-Based Community Health Worker Intervention to Increase Colorectal Cancer Screening Among Latinos.

  De La Torre CL, Dumbauld JN, Haughton J, Gupta S, Nodora J, Giacinto RE, Ramers C, Bharti B, Wells K, Lopez J, Díaz M, Moody J, Arredondo EM. De La Torre CL, et al. Hisp Health Care Int. 2021 Mar;19(1):47-54. doi: 10.1177/1540415320923564. Epub 2020 May 29. Hisp Health Care Int. 2021. PMID: 32466687 Free PMC article. Review.

• Contribution of patient, physician, and environmental factors to demographic and health variation in colonoscopy follow-up for abnormal colorectal cancer screening test results.

  Partin MR, Gravely AA, Burgess JF Jr, Haggstrom DA, Lillie SE, Nelson DB, Nugent SM, Shaukat A, Sultan S, Walter LC, Burgess DJ. Partin MR, et al. Cancer. 2017 Sep 15;123(18):3502-3512. doi: 10.1002/cncr.30765. Epub 2017 May 11. Cancer. 2017. PMID: 28493543 Free PMC article.

• Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue.

  Levin TR, Corley DA, Jensen CD, Marks AR, Zhao WK, Zebrowski AM, Quinn VP, Browne LW, Taylor WR, Ahlquist DA, Lidgard GP, Berger BM. Levin TR, et al. Dig Dis Sci. 2017 Mar;62(3):678-688. doi: 10.1007/s10620-016-4433-6. Epub 2017 Jan 2. Dig Dis Sci. 2017. PMID: 28044229 Free PMC article.

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3